Abstract:BACKGROUND: Endoplasmic reticulum (ER) stress impairs ER functions and leads to the accumulation of unfolded or misfolded proteins in the ER lumen. ER stress-induced cell death plays an important role in cerebral ischemia. Edaravon (3-methyl-1-phenyl-2-pyrazolin-5-one) is a potent and novel scavenger of free radicals that inhibit delayed neuronal death, as demonstrated by in vitro and animal studies. However, its effect on ER stress and induced neuronal apoptosis in a rat model of brief middle cerebral artery occlusion remains unclear.OBJECTIVE: To explore the effects of edaravone on the expression of ER stress-related factors and neuronal apoptosis, based on the hypothesis that edaravone influences ER stress in a rat model of cerebral ischemia/reperfusion.DESIGN, TIME AND SETTING: A randomized, controlled, animal study was performed at the Laboratory of Department of Neurology, Xiangya Hospital and the Department of Laboratory Animals, Xiangya Medical College, Central South University in China from June 2005 to May 2006.MATERIALS: Edaravone was purchased from Simcere Pharmaceutical Group, China.METHODS: A total of 216 adult, male, Sprague Dawley rats were randomly assigned to sham-surgery, model and edaravone groups, with 72 rats in each group. Brief middle cerebral artery occlusion was established in the model and edaravone groups. In addition, the edaravone group rats were injected with 3 mg/kg edaravone through the tail vein.MAIN OUTCOME MEASURES: RNA-dependent protein kinase-like endoplasmic reticulum eukaryotic translation initiation factor 2 alpha kinase (PERK) and C/EBP homology protein (CHOP) mRNA expression in the ischemic parietal cortex was determined by reverse transcription-polymerase chain reaction; phosphorylated PERK and CHOP protein expression was detected by immunohistochemistry, neuronal apoptosis was detected by TdT-mediated-dUTP nick end labeling.RESULTS: Neurological deficit scores were significantly reduced in the edaravone group compared to the model group at 12, 24, and 72 hours following reperfusion (P < 0.05). In addition, PERK and CHOP mRNA as well as phosphorylated PERK and CHOP protein expression were significantly reduced in the edaravone group compared to the model group at 1, 3, and 6 hours following reperfusion (P < 0.05, P < 0.01). CHOP mRNA expression was decreased in the edaravone group compared to the model group at 3, 6, 12, and 24 hours following reperfusion (P < 0.01), while CHOP protein expression was less than the model group at 6, 12, and 24 hours following reperfusion (P < 0.05).CONCLUSION: Edaravone treatment resulted in decreased PERK and CHOP expression following ischemia/reperfusion, as well as reduced neuronal apoptosis. Edaravone exhibited a neuroprotective role by inhibiting endoplasmic reticulum stress.

Edaravone alleviated propofol‐induced neural injury in developing rats by BDNF/TrkB pathway

Edaravone Alleviated Propofol-Induced Neurotoxicity in Developing Hippocampus by Mbdnf/trkb/pi3k Pathway

Neuroprotective effect of edaravone on focal cerebral ischemia in rats

Effect of edaravone against oxidative damage caused by acute craniocerebral trauma

Protective Effects of Edaravone on Renal Ischemia-Reperfusion Injury in Rats

Edaravone Attenuates Neuronal Apoptosis in Hippocampus of Rat Traumatic Brain Injury Model Via Activation of BDNF/TrkB Signaling Pathway

Edaravone Protects Primary-Cultured Rat Cortical Neurons from Ketamine-Induced Apoptosis Via Reducing Oxidative Stress and Activating PI3K/Akt Signal Pathway

Neuroprotective Role of Edaravone and the Effects of Endoplasmic Reticulum Stress in an Adult Rat Model of Focal Cerebral Ischemia/Reperfusion

Edaravone Dexborneol provides neuroprotective effect by inhibiting neurotoxic activation of astrocytes through inhibiting NF-κB signaling in cortical ischemia

Edaravone Protects PC12 Cells from Ischemic-Like Injury Via Attenuating the Damage to Mitochondria

Free-radical Scavenger Edaravone Treatment Confers Neuroprotection Against Traumatic Brain Injury in Rats.

Pre- and Post-Treatment with Edaravone Protects CA1 Hippocampus and Enhances Neurogenesis in the Subgranular Zone of Dentate Gyrus after Transient Global Cerebral Ischemia in Rats

Edaravone Dexborneol Alleviates Cerebral Ischemic Injury via MKP-1-Mediated Inhibition of MAPKs and Activation of Nrf2

Edaravone dexborneol regulates γ-aminobutyric acid transaminase in rats with acute intracerebral hemorrhage

Edaravone Protects Cortical Neurons from Apoptosis by Inhibiting the Translocation of Bax and Increasing the Interaction Between 14-3-3 and P-Bad

Edaravone dexborneol protects against cerebral ischemia/reperfusion-induced blood-brain barrier damage by inhibiting ferroptosis via activation of nrf-2/HO-1/GPX4 signaling

Edaravone protects rat astrocytes from oxidative or neurotoxic inflammatory insults by restoring Akt/Bcl-2/Caspase-3 signaling axis

Edaravone dexborneol protects cerebral ischemia reperfusion injury through activating Nrf2/HO‐1 signaling pathway in mice

Edaravone Dexborneol Alleviates Neuroinflammation by Reducing Neuroglial Cell Proliferation and Suppresses Neuronal Apoptosis/Autophagy in Vascular Dementia Rats

Protective Effect of Edaravone on Ventilator Induced Lung Injury in Rats

Protective Effect of Edaravone on Central Nervous System Damage Induced by 1-Bromopropane in Rats